NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 341 filers reported holding NEKTAR THERAPEUTICS in Q2 2019. The put-call ratio across all filers is 2.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $545,000 | +4.6% | 30,362 | 0.0% | 0.01% | +22.2% |
| Q2 2021 | $521,000 | -14.3% | 30,362 | -0.1% | 0.01% | -18.2% |
| Q1 2021 | $608,000 | -42.0% | 30,389 | -50.7% | 0.01% | -21.4% |
| Q4 2020 | $1,049,000 | -26.8% | 61,684 | -0.4% | 0.01% | -30.0% |
| Q3 2020 | $1,434,000 | 0.0% | 61,932 | 0.0% | 0.02% | 0.0% |
| Q2 2020 | $1,434,000 | +31.4% | 61,932 | +1.3% | 0.02% | +17.6% |
| Q1 2020 | $1,091,000 | +0.6% | 61,137 | +21.7% | 0.02% | -15.0% |
| Q4 2019 | $1,085,000 | +789.3% | 50,247 | +652.8% | 0.02% | +566.7% |
| Q3 2019 | $122,000 | -48.1% | 6,675 | +1.0% | 0.00% | -50.0% |
| Q2 2019 | $235,000 | -73.6% | 6,611 | -75.0% | 0.01% | -62.5% |
| Q1 2019 | $889,000 | +3.7% | 26,456 | +1.5% | 0.02% | +14.3% |
| Q4 2018 | $857,000 | -53.4% | 26,061 | -13.6% | 0.01% | -50.0% |
| Q3 2018 | $1,840,000 | +22.1% | 30,180 | -2.2% | 0.03% | +27.3% |
| Q2 2018 | $1,507,000 | -51.6% | 30,853 | +5.3% | 0.02% | -57.7% |
| Q1 2018 | $3,113,000 | – | 29,293 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
| GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
| Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
| Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
| MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
| Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
| Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
| CM Management, LLC | 50,000 | $898,000 | 0.67% |
| Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |